Royal Bank of Canada
AIFF

Royal Bank of Canada’s Firefly Neuroscience AIFF Stock Holding History

Royal Bank of Canada’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
41
+40
+4,000% +$50 ﹤0.01% 7819
2025
Q4 		$0 Hold
1
– – ﹤0.01% 7760
2025
Q3 		$0 Sell
1
-500
-100% -$1.42K ﹤0.01% 7621
2025
Q2 		$1K Sell
501
-2,000
-80% -$6.34K ﹤0.01% 6959
2025
Q1 		$10K Buy
2,501
+2,500
+250,000% +$11.5K ﹤0.01% 6173
2024
Q4 		$0 Sell
1
-22
-96% -$68 ﹤0.01% 7343
2024
Q3 		$0 Buy
23
+15
+188% +$79 ﹤0.01% 7582
2024
Q2 		$0 Hold
8
– – ﹤0.01% 7631
2024
Q1 		$0 Sell
8
-17
-68% -$114 ﹤0.01% 7706
2023
Q4 		$0 Hold
25
– – ﹤0.01% 7671
2023
Q3 		$0 Sell
25
-2
-7% -$20 ﹤0.01% 7695
2023
Q2 		$0 Buy
+27
New +$306 ﹤0.01% 7730
2022
Q4 		– Sell
-7
Closed – – 7815
2022
Q3 		$0 Buy
+7
New +$257 ﹤0.01% 7954

Other funds holding AIFF

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Royal Bank of Canada's AIFF Position: Q1 2026 in Review

Royal Bank of Canada increased its Firefly Neuroscience (AIFF) stake by 4,000% in Q1 2026, buying an estimated $50 and bringing the position to 41 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7819.

Royal Bank of Canada first reported a position in AIFF in Q3 2022 and has held it in 13 quarters since. The position peaked at $10K in Q1 2025. 23 funds tracked by Wall St. Rank hold AIFF as of Q1 2026.

  • Royal Bank of Canada held 41 shares of Firefly Neuroscience worth $0 as of Q1 2026.
  • Royal Bank of Canada bought 40 Firefly Neuroscience shares in Q1 2026, an estimated $50.
  • Firefly Neuroscience made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7819 holding.
  • Royal Bank of Canada first reported a position in Firefly Neuroscience in Q3 2022 and has held it in 13 quarters since.
  • Royal Bank of Canada's Firefly Neuroscience position peaked at $10K in Q1 2025.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.